Friedreich Ataxia Trial, Not Yet Recruiting NCT07731971 Sponsor: University of Exeter Condition: Friedreich Ataxia
Back to Friedreich Ataxia

Friedreich Ataxia Trial, Not Yet Recruiting

NCT07731971
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

Friedreich ataxia group:

  • People aged 12 to 50 years who have been diagnosed with Friedreich ataxia through genetic testing
  • People who are able to sit or stand on their own for at least 5 minutes
  • People who are able to give informed consent, or, if under 16 years old, able to give assent with a parent or guardian also giving consent
  • People whose medications have not changed in the past 4 weeks

Healthy control group:

  • People aged 12 to 50 years who have not been diagnosed with Friedreich ataxia through genetic testing
  • People who are able to sit or stand on their own for at least 5 minutes
  • People who are able to give informed consent, or, if under 16 years old, able to give assent with a parent or guardian also giving consent

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

Friedreich ataxia group:

  • People aged 11 years or younger, or 51 years or older
  • People with severe cognitive difficulties that would prevent them from understanding and completing the trial tasks
  • People with an active seizure condition, or a balance or inner ear problem that causes nausea when using non-immersive virtual reality
  • People who are currently taking part in another interventional clinical trial
  • People without a reliable internet connection that cannot be resolved by a digital support kit provided by the trial (confirm with trial site)
  • People with any health reason that would make it unsafe to take part in moderate-intensity exercise

Healthy control group:

  • People aged 11 years or younger, or 51 years or older
  • People who have been diagnosed with Friedreich ataxia through genetic testing
  • People with any health reason that would make it unsafe to take part in moderate-intensity exercise

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 17 August 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Helen Dawes, University of Exeter

Phone: +44 (0) 1392 661000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
University of Exeter
Registry
ClinicalTrials.gov
Start date
30 July 2026
Est. completion
31 December 2026

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

Concurrent validity of game-based movement performance against the mFARS - Friedreich ataxia cohort.; Criterion validity of AI markerless motion capture versus marker-based motion capture - Healthy Controls and Friedreich Ataxia; Comparison of the digital COA metrics between healthy control and Friedreich ataxia cohort.; Responsiveness of digital COA metrics over time; Patient Global Impression of Change (PGIC); Platform acceptability and usability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 17 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov